AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32404535 — intervention group
Group type: COMPARATOR
Intervention: Regular training (RT)
Number of subjects: 0
Study 32643561 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomy-supportive intervention
Number of subjects: 256
Study 32643561 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 256
Study 33244038 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA test without sojourn time correction
Number of subjects: 20796
Study 33244038 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA test with sojourn time correction
Number of subjects: 20796
Study 35459100 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation with a preoperative exercise and education program delivered over 4 to 8 weeks before surgery.
Number of subjects: 172
Study 35459100 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation with a preoperative exercise and education program.
Number of subjects: 172
Study 35459100 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (control group).
Number of subjects: 172
Study 32735653 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezlotoxumab (alone or with actoxumab)
Number of subjects: 1588
Study 32735653 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo or actoxumab)
Number of subjects: 1588
Study 32533012 — intervention group
Group type: EXPERIMENTAL
Intervention: TT genotype of rs165728
Number of subjects: 0
Study 32533012 — intervention group
Group type: EXPERIMENTAL
Intervention: TT genotype of rs174699
Number of subjects: 0
Study 32533012 — intervention group
Group type: EXPERIMENTAL
Intervention: GG genotype at rs4680 G > A
Number of subjects: 0
Study 32533012 — intervention group
Group type: EXPERIMENTAL
Intervention: CC genotype at rs4633
Number of subjects: 0
Study 32533012 — intervention group
Group type: COMPARATOR
Intervention: rs174675 T and rs933271 C alleles
Number of subjects: 0
Study 36362620 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified clinical pharmacological/pharmaceutical care program
Number of subjects: 202
Study 34244807 — intervention group
Group type: EXPERIMENTAL
Intervention: QI coaching
Number of subjects: 855
Study 34244807 — intervention group
Group type: COMPARATOR
Intervention: Communication training
Number of subjects: 855
Study 34244807 — intervention group
Group type: COMPARATOR
Intervention: Combined intervention
Number of subjects: 855
Study 33710466 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (measured as number of cigarettes smoked per day)
Number of subjects: 1008
Study 33710466 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (specifically rs1051730 T alleles in ever smokers)
Number of subjects: 1008
Study 33710466 — intervention group
Group type: COMPARATOR
Intervention: Control group (never smokers)
Number of subjects: 1008
Study 33087145 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-esterified DHA (975 mg for 30 days)
Number of subjects: 38
Study 33087145 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-esterified DHA
Number of subjects: 38
Study 33087145 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 38
Study 35701734 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0
Study 35701734 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33842996 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD+AA/PRF
Number of subjects: 20
Study 33842996 — intervention group
Group type: COMPARATOR
Intervention: OFD+PRF
Number of subjects: 20
Study 33596968 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided ESP block with 40 ml 0.25% levo-bupivacaine (20 ml each side) post induction of general anaesthesia and before surgical incision.
Number of subjects: 50
Study 33596968 — intervention group
Group type: COMPARATOR
Intervention: Standardised analgesic protocol (same for both groups).
Number of subjects: 50
Study 34427233 — intervention group
Group type: COMPARATOR
Intervention: Human amniotic membrane
Number of subjects: 12
Study 34427233 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-treated poly-?-caprolactone (pPCL) membrane
Number of subjects: 12
Study 33049973 — intervention group
Group type: COMPARATOR
Intervention: LNS-S (sweetened SQ-LNS)
Number of subjects: 78
Study 33049973 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS-U (unsweetened SQ-LNS)
Number of subjects: 78
Study 33049973 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LNS-S and LNS-U
Number of subjects: 78
Study 35271495 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (ascorbic acid) administered three times a week for three months
Number of subjects: 32
Study 32596937 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods of skin protection for nasogastric tubes
Number of subjects: 87
Study 32596937 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods of skin protection for endotracheal tubes
Number of subjects: 87
Study 32596937 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall intervention
Number of subjects: 87
Study 32596937 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment process
Number of subjects: 87
Study 35659904 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV vaccine
Number of subjects: 3983
Study 35659904 — intervention group
Group type: EXPERIMENTAL
Intervention: OnSite IgG RDT
Number of subjects: 3983
Study 35340961 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% isobaric levobupivacaine with 75‐mg magnesium sulfate
Number of subjects: 60
Study 35340961 — intervention group
Group type: COMPARATOR
Intervention: 0.5% hyperbaric bupivacaine with 75‐mg magnesium sulfate
Number of subjects: 60
Study 32951292 — intervention group
Group type: EXPERIMENTAL
Intervention: Gracilaria algae cream 3%
Number of subjects: 30
Study 32951292 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol cream 0.05%
Number of subjects: 30
Study 34006553 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the Dutch Prospective Bladder Cancer Infrastructure (ProBCI) study, which includes extensive clinical data collection and patient-reported outcomes.
Number of subjects: 0
Study 34006553 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes collected every 4 months.
Number of subjects: 0
Study 34006553 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent for participation in questionnaires and molecular analyses.
Number of subjects: 0
Study 32272513 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramide-containing moisturizing cream
Number of subjects: 0
Study 36153168 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary instrumentation technique
Number of subjects: 90
Study 36153168 — intervention group
Group type: COMPARATOR
Intervention: Manual instrumentation technique
Number of subjects: 90
Study 33638278 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive online informational and peer support app for LARS
Number of subjects: 69
Study 33638278 — intervention group
Group type: EXPERIMENTAL
Intervention: Online peer support for LARS
Number of subjects: 69
Study 33638278 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <65 years
Number of subjects: 69
Study 33638278 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor/major LARS
Number of subjects: 69
Study 32052694 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher objective numeracy
Number of subjects: 0
Study 32052694 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher subjective numeracy
Number of subjects: 0
Study 32052694 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher math anxiety
Number of subjects: 0
Study 32052694 — intervention group
Group type: EXPERIMENTAL
Intervention: Math anxiety
Number of subjects: 0
Study 32052694 — intervention group
Group type: EXPERIMENTAL
Intervention: Education initiatives
Number of subjects: 0
Study 34131999 — intervention group
Group type: EXPERIMENTAL
Intervention: Babu and Magon uterine closure technique
Number of subjects: 72
Study 34131999 — intervention group
Group type: COMPARATOR
Intervention: Double-layer closure of the uterine incision
Number of subjects: 72
Study 32145348 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 289831
Study 35421696 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific lower deep neck extensors (SLDNE) exercise program
Number of subjects: 43
Study 35421696 — intervention group
Group type: EXPERIMENTAL
Intervention: General neck extensor (GNE) exercise program
Number of subjects: 43
Study 34486701 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-smokers (G1)
Number of subjects: 61
Study 34486701 — intervention group
Group type: COMPARATOR
Intervention: Smokers (G2)
Number of subjects: 61
Study 35706490 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg intravenous ferric carboxymaltose (iron)
Number of subjects: 32
Study 35706490 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 32
Study 32871552 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Stretching Warm-Up (DS-WU)
Number of subjects: 12
Study 32871552 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric Warm-Up (PL-WU)
Number of subjects: 12
Study 32871552 — intervention group
Group type: COMPARATOR
Intervention: Comparison of DS-WU and PL-WU
Number of subjects: 12
Study 34448877 — intervention group
Group type: EXPERIMENTAL
Intervention: German-language Tinnitus Functional Index (TFI) for Germany
Number of subjects: 0
Study 34448877 — intervention group
Group type: COMPARATOR
Intervention: German-language Tinnitus Functional Index (TFI) for Switzerland
Number of subjects: 0
Study 33961310 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab 5 mg/kg every 4 weeks
Number of subjects: 19
Study 33961310 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab 20 mg/kg every 4 weeks
Number of subjects: 19
Study 33961310 — intervention group
Group type: EXPERIMENTAL
Intervention: Domagrozumab 40 mg/kg every 4 weeks
Number of subjects: 19
Study 33961310 — intervention group
Group type: EXPERIMENTAL
Intervention: Extension study of domagrozumab
Number of subjects: 19
Study 33961310 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 19
Study 32538148 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemocontrol hemodialysis (HHD)
Number of subjects: 29
Study 32538148 — intervention group
Group type: COMPARATOR
Intervention: Standard hemodialysis (SHD)
Number of subjects: 29
Study 32538148 — intervention group
Group type: EXPERIMENTAL
Intervention: HHD
Number of subjects: 29
Study 32538148 — intervention group
Group type: COMPARATOR
Intervention: SHD
Number of subjects: 29
Study 33964925 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lefamulin (150 mg every 12 h) for 5–7 days
Number of subjects: 1289
Study 33964925 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral lefamulin (600 mg every 12 h) for 5 days
Number of subjects: 1289
Study 33964925 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg every 24 h) for 7 days
Number of subjects: 1289
Study 33049929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mankai-containing green Mediterranean/low-meat diet
Number of subjects: 294
Study 33049929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 294
Study 33049929 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 294
Study 35759733 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (P) 135 mg/m2 once every 28 days for 12 cycles
Number of subjects: 1157
Study 35759733 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel poliglumex (PP) 135 mg/m2 once every 28 days for 12 cycles
Number of subjects: 1157
Study 35759733 — intervention group
Group type: COMPARATOR
Intervention: Surveillance (S)
Number of subjects: 1157
Study 34530679 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmentally adapted cognitive processing therapy (D‐CPT)
Number of subjects: 43
Study 34530679 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition with treatment advice (WL/TA)
Number of subjects: 43
Study 32049627 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphate content in medications prescribed to HD patients
Number of subjects: 695759
Study 32049627 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring of medications containing phosphate
Number of subjects: 695759
Study 36350907 — intervention group
Group type: EXPERIMENTAL
Intervention: Pachy‐100
Number of subjects: 12
Study 36350907 — intervention group
Group type: EXPERIMENTAL
Intervention: Pachy‐50
Number of subjects: 12
Study 36350907 — intervention group
Group type: EXPERIMENTAL
Intervention: Pachy‐0
Number of subjects: 12
Study 36350907 — intervention group
Group type: EXPERIMENTAL
Intervention: Pachy+50
Number of subjects: 12
Study 33416291 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive disorders of pregnancy
Number of subjects: 119408
Study 33416291 — intervention group
Group type: COMPARATOR
Intervention: No hypertensive disorders of pregnancy
Number of subjects: 119408
Study 33136422 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 290
Study 33136422 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Education (EDU)
Number of subjects: 290
Study 34969033 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen with intravitreal ranibizumab 0.5 mg
Number of subjects: 139
Study 34969033 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-monthly to treat-and-extend (OM-T&E) regimen with intravitreal ranibizumab 0.5 mg
Number of subjects: 139
Study 34969033 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 139
Study 34969033 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-monthly to treat-and-extend (OM-T&E) regimen
Number of subjects: 139
Study 33633081 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole treatment
Number of subjects: 48
Study 33633081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 33633081 — intervention group
Group type: COMPARATOR
Intervention: D fragilis-negative children
Number of subjects: 48
Study 36190330 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A specific activity in plasma (SAp)
Number of subjects: 12
Study 36190330 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A specific activity in milk (SAm)
Number of subjects: 12
Study 36190330 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of SAp and SAm
Number of subjects: 12
Study 36190330 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated FaS using SAp
Number of subjects: 12
Study 36190330 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated FaS using SAm
Number of subjects: 12
Study 34538818 — intervention group
Group type: EXPERIMENTAL
Intervention: MPK + HYD
Number of subjects: 9
Study 34538818 — intervention group
Group type: EXPERIMENTAL
Intervention: MPK + RIG
Number of subjects: 9
Study 34538818 — intervention group
Group type: EXPERIMENTAL
Intervention: NMPK + HYD
Number of subjects: 9
Study 34538818 — intervention group
Group type: EXPERIMENTAL
Intervention: NMPK + RIG
Number of subjects: 9
Study 32965037 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose melatonin (4 mg for <40 kg; 8 mg for ≥40 kg)
Number of subjects: 84
Study 32965037 — intervention group
Group type: COMPARATOR
Intervention: Low-dose melatonin (1 mg for <40 kg; 2 mg for ≥40 kg)
Number of subjects: 84
Study 32965037 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose melatonin
Number of subjects: 84
Study 32965037 — intervention group
Group type: COMPARATOR
Intervention: Low-dose melatonin
Number of subjects: 84
Study 36700975 — intervention group
Group type: EXPERIMENTAL
Intervention: Pusen Uscope 3011
Number of subjects: 60
Study 36700975 — intervention group
Group type: COMPARATOR
Intervention: LithoVue
Number of subjects: 60
Study 34836393 — intervention group
Group type: EXPERIMENTAL
Intervention: 52 mL/day of EVOO (n = 50)
Number of subjects: 149
Study 34836393 — intervention group
Group type: EXPERIMENTAL
Intervention: DieTBra (n = 49)
Number of subjects: 149
Study 34836393 — intervention group
Group type: EXPERIMENTAL
Intervention: DieTBra + 52 mL/day of EVOO (n = 50)
Number of subjects: 149
Study 32702660 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 20
Study 32702660 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrument-Assisted Soft Tissue Mobilization (IASTM)
Number of subjects: 20
Study 32702660 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 20
Study 34822251 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anaesthetic (group A)
Number of subjects: 35
Study 34822251 — intervention group
Group type: COMPARATOR
Intervention: No anaesthetic gel (group B)
Number of subjects: 35
Study 33080415 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine 4 μg/min
Number of subjects: 82
Study 33080415 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine 50 μg/min
Number of subjects: 82
Study 34218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrachoric correlation coefficient computed with Kirk's approach
Number of subjects: 0
Study 34218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of variance estimator of the ICC
Number of subjects: 0
Study 34218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficient (ICC)
Number of subjects: 0
Study 34218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Variance partition coefficient
Number of subjects: 0
Study 34218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Median odds ratio
Number of subjects: 0
Study 34218744 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative deviation of an ICC estimate to the theoretical maximum possible value
Number of subjects: 0
Study 33203685 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person follow-up visit
Number of subjects: 66
Study 33203685 — intervention group
Group type: COMPARATOR
Intervention: Video call via mobile phone application
Number of subjects: 66
Study 35281034 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (15 µg daily for 12 weeks)
Number of subjects: 0
Study 35281034 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D2 (15 µg daily for 12 weeks)
Number of subjects: 0
Study 35281034 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not specified dosage or duration)
Number of subjects: 0
Study 33991392 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing turmeric and licorice extract
Number of subjects: 90
Study 33991392 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice
Number of subjects: 90
Study 36259119 — intervention group
Group type: EXPERIMENTAL
Intervention: Early 2‐stage palatoplasty (ETS group)
Number of subjects: 86
Study 36259119 — intervention group
Group type: COMPARATOR
Intervention: 1‐stage pushback palatoplasty (PB group)
Number of subjects: 86
Study 33422476 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasting before acid etching (SBE group)
Number of subjects: 20
Study 33422476 — intervention group
Group type: COMPARATOR
Intervention: Acid etching only (E group)
Number of subjects: 20
Study 33422476 — intervention group
Group type: COMPARATOR
Intervention: Initial bonding (IB group)
Number of subjects: 20
Study 32109317 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + folic acid (SRP + F)
Number of subjects: 60
Study 32109317 — intervention group
Group type: COMPARATOR
Intervention: SRP + placebo (SRP + P)
Number of subjects: 60
Study 35140794 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous walking (CON) for 30 min, 3 days/week for 12 weeks
Number of subjects: 43
Study 35140794 — intervention group
Group type: COMPARATOR
Intervention: Intermittent walking (INT) split into 3 sessions of 10 min with 1 min rest, 3 days/week for 12 weeks
Number of subjects: 43
Study 35140794 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CON and INT)
Number of subjects: 43
Study 33290248 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin plus rosiglitazone
Number of subjects: 699
Study 33290248 — intervention group
Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 699
Study 33290248 — intervention group
Group type: COMPARATOR
Intervention: Metformin plus intensive lifestyle intervention
Number of subjects: 699
Study 33290248 — intervention group
Group type: COMPARATOR
Intervention: Routine diabetes care after discontinuation of rosiglitazone
Number of subjects: 699
Study 32631074 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) 5 days/week
Number of subjects: 25
Study 32631074 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (simulated microcurrent electrical nerve stimulation) 5 days/week
Number of subjects: 25
Study 33070667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 33070667 — intervention group
Group type: COMPARATOR
Intervention: Diabetes Education (ED)
Number of subjects: 0
Study 33747319 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 30
Study 33747319 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac tromethamine (KT)
Number of subjects: 30
Study 32660521 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume preparation
Number of subjects: 25
Study 32660521 — intervention group
Group type: COMPARATOR
Intervention: High-volume preparation
Number of subjects: 25
Study 32660521 — intervention group
Group type: COMPARATOR
Intervention: Medium-volume preparation
Number of subjects: 25
Study 36045651 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics supplementation for 8 weeks
Number of subjects: 40
Study 36045651 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 40
Study 33916559 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster‐Based Energy Optimization with Mobile Sink (CEOMS) algorithm
Number of subjects: 0
Study 33916559 — intervention group
Group type: COMPARATOR
Intervention: Low Energy Adaptive Clustering Hierarchy Protocol (LEACH) architecture
Number of subjects: 0
Study 34779576 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib (UPA) 15 mg
Number of subjects: 338
Study 34779576 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 338
Study 33472997 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop target controlled infusion (CLTCI) of propofol
Number of subjects: 70
Study 33472997 — intervention group
Group type: COMPARATOR
Intervention: Open-loop target controlled infusion (OLTCI) of propofol
Number of subjects: 70